XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/national/2019/09/16/lundbeck-paying-nearly-2b-for-alder-to-follow-migraine-rivals-to-market/60%Monthly2019-09-17 01:09
https://xconomy.com/san-francisco/2019/09/16/why-menlo-ventures-backed-its-first-construction-tech-firm/60%Monthly2019-09-16 04:22
https://xconomy.com/san-francisco/2019/09/13/advisory-body-backs-aimmune-peanut-allergy-drug-next-up-the-fda/60%Monthly2019-09-14 02:46
https://xconomy.com/new-york/2019/09/13/baceless-eisai-biogen-pull-plug-on-alzheimers-drug-in-final-stage/60%Monthly2019-09-13 17:31
https://xconomy.com/san-francisco/2019/09/13/cloudflares-525m-ipo-emboldens-already-confident-internet-booster/60%Monthly2019-09-13 21:11
https://xconomy.com/boston/2019/09/13/boston-tech-watch-neural-galaxy-link-ventures-more-epstein-fallout/60%Monthly2019-09-13 11:59
https://xconomy.com/national/2019/09/13/bio-roundup-award-winners-lung-data-dems-on-drug-pricing-more/60%Monthly2019-09-13 10:46
https://xconomy.com/wisconsin/2019/09/13/booming-cs-demand-brings-ex-acquia-ceo-back-to-his-uw-roots/60%Monthly2019-09-13 12:12
https://xconomy.com/san-francisco/2019/09/12/springworks-and-satsuma-boost-this-weeks-biotech-ipo-haul-to-595m/60%Monthly2019-09-13 17:58
https://xconomy.com/boston/2019/09/12/the-winners-of-the-2019-xconomy-awards-boston-are/60%Monthly2019-09-13 00:24
https://xconomy.com/san-diego/2019/09/12/tocagen-stock-tanks-after-gene-therapy-drug-for-brain-cancer-fails/60%Monthly2019-09-12 18:15
https://xconomy.com/boston/2019/09/12/john-halamka-livongo-health-ai-progress-at-x%c2%b7con-on-oct-22/60%Monthly2019-09-11 18:52
https://xconomy.com/seattle/2019/09/11/as-more-grocers-embrace-tech-swiftly-snags-15m-to-launch-in-seattle/60%Monthly2019-09-13 17:10
https://xconomy.com/san-francisco/2019/09/11/fda-doesnt-shell-peanut-allergy-drug-pre-hearing-aimmune-shares-climb/60%Monthly2019-09-12 14:40
https://xconomy.com/san-diego/2019/09/11/after-investing-gsk-to-buy-out-celiac-drug-developer-sitari-pharma/60%Monthly2019-09-11 18:47
https://xconomy.com/boston/2019/09/11/phil-sharp-crispring-the-heart-the-duchenne-data-gap-on-oct-17/60%Monthly2019-09-12 11:19
https://xconomy.com/national/2019/09/10/after-first-look-at-house-drug-plan-stocks-rise-slightly/60%Monthly2019-09-10 21:53
https://xconomy.com/san-francisco/2019/09/10/blackthorn-therapeutics-names-monique-levy-chief-strategy-officer/60%Monthly2019-09-10 16:01
https://xconomy.com/national/2019/09/10/herceptin-inventors-immunology-pioneers-take-home-2019-lasker-awards/60%Monthly2019-09-10 13:21
https://xconomy.com/boston/2019/09/10/shopify-buys-6-river-systems-for-450m-to-boost-new-fulfillment-centers/60%Monthly2019-09-10 13:26
https://xconomy.com/san-francisco/2019/09/10/challenging-crispr-trucode-raises-34m-for-new-gene-editing-system/60%Monthly2019-09-10 16:07
https://xconomy.com/san-diego/2019/09/10/san-diego-life-sciences-roundup-sgi-dna-zeakal-delmar-pharma-more/60%Monthly2019-09-10 06:33
https://xconomy.com/boston/2019/09/10/your-car-is-hackable-here-are-three-steps-you-can-take/60%Monthly2019-09-10 15:52
https://xconomy.com/seattle/2019/09/09/amazon-with-more-wa-workers-than-microsoft-eyes-adding-10k-more/60%Monthly2019-09-10 16:51
https://xconomy.com/san-diego/2019/09/09/acadia-stock-jumps-on-positive-dementia-related-psychosis-drug-data/60%Monthly2019-09-09 22:08
https://xconomy.com/boston/2019/09/09/joi-ito-media-lab-resign-jeffrey-epstein-knight-macarthur-pretech-nytimes-harvard/60%Monthly2019-09-10 17:09
https://xconomy.com/boston/2019/09/09/genfit-names-carol-addy-to-chief-medical-officer-role/60%Monthly2019-09-09 17:06
https://xconomy.com/boston/2019/09/09/as-new-ceo-of-cerevel-coles-moves-from-one-neuro-startup-to-another/60%Monthly2019-09-09 14:25
https://xconomy.com/national/2019/09/09/at-big-lung-cancer-meeting-lights-shine-on-kras-drug-combos-more/60%Monthly2019-09-09 12:44
https://xconomy.com/seattle/2019/09/06/home-buying-tech-startup-savvy-lane-lands-2m-for-west-coast-growth/60%Monthly2019-09-07 00:58
https://xconomy.com/boston/2019/09/06/frequency-plans-ipo-for-hearing-loss-drug-more-regenerative-meds/60%Monthly2019-09-07 15:36
https://xconomy.com/national/2019/09/06/bio-roundup-medcos-pricing-plan-vertexs-gamble-ubiome-undone/60%Monthly2019-09-06 11:17
https://xconomy.com/boston/2019/09/06/boston-tech-watch-mit-epstein-notarize-cash-new-carbonite-execs/60%Monthly2019-09-05 18:30
https://xconomy.com/wisconsin/2019/09/06/wi-watchlist-epic-frontdesk-shine-startingblock-madison-more/60%Monthly2019-09-05 23:21
https://xconomy.com/boston/2019/09/05/novartis-ifm-team-up-again-with-buyout-option-for-autoimmune-rd/60%Monthly2019-09-05 15:33
https://xconomy.com/san-diego/2019/09/05/startup-aquacycl-raises-4m-to-more-efficiently-treat-wastewater/60%Monthly2019-09-05 02:30
https://xconomy.com/boston/2019/09/05/cogito-raises-20m-to-expand-call-center-emotional-intelligence/60%Monthly2019-09-05 01:22
https://xconomy.com/san-francisco/2019/09/04/sfs-ginger-raises-35m-in-burgeoning-digital-therapeutics-market/60%Monthly2019-09-05 13:23
https://xconomy.com/boston/2019/09/04/synlogics-c-suite-adds-richard-riese-cfo-todd-shegog-to-depart/60%Monthly2019-09-04 21:46
https://xconomy.com/seattle/2019/09/04/as-clean-power-buying-surges-levelten-helps-firms-track-energy-data/60%Monthly2019-09-04 20:53
https://xconomy.com/san-francisco/2019/09/04/bankrupt-ubiome-says-founders-may-have-misled-investors/60%Monthly2019-09-05 05:22
https://xconomy.com/san-francisco/2019/09/04/bolt-biotherapeutics-taps-ex-alder-executive-randy-schatzman-as-ceo/60%Monthly2019-09-04 19:23
https://xconomy.com/boston/2019/09/04/former-nightstar-exec-gregory-robinson-joins-akouos-as-chief-scientific-officer/60%Monthly2019-09-04 19:17
https://xconomy.com/san-francisco/2019/09/03/vir-bio-plans-ipo-to-fund-clinical-trials-of-infectious-disease-drugs/60%Monthly2019-09-06 01:52
https://xconomy.com/boston/2019/09/03/accent-therapeutics-taps-tangos-shakti-narayan-for-ceo/60%Monthly2019-09-04 14:38
https://xconomy.com/texas/2019/09/03/former-alnylam-executive-soni-joins-reata-pharmaceuticals-as-cfo/60%Monthly2019-09-04 14:35
https://xconomy.com/san-diego/2019/09/03/aristea-therapeutics-taps-nihar-bhakta-as-chief-medical-officer/60%Monthly2019-09-04 14:40
https://xconomy.com/boston/2019/09/03/vertex-bets-950m-on-semma-and-a-stem-cell-therapy-for-diabetes/60%Monthly2019-09-04 16:34
https://xconomy.com/boston/2019/09/03/with-fdas-eye-on-jak-drugs-concert-pharma-moves-one-ahead-for-hair-loss/60%Monthly2019-09-03 10:59
https://xconomy.com/new-york/2019/09/02/as-cholesterol-drug-aces-big-test-medco-ceo-open-to-flexible-pricing/60%Monthly2019-09-03 11:13